Elevian Company
Biotech company spun out of Harvard University in 2017, headquartered in Cambridge, Massachusetts. Elevian develops therapies based on circulating rejuvenation factors, focusing on GDF11-related biology. Its pipeline addresses age-related and regenerative conditions by stimulating tissue repair, neuroprotection, and cardiovascular recovery. (elevian.com)
Investors
Headquarters:
90 Bridge Street, Suite 100, Newton, MA 02458, United State
Employee Number:
30
Estimated Revenue:
No public info
Founded Date:
2017